Chlorophyll-Based Cardiac Patch Improved Heart Function

Researchers developed a resilient hydrogel patch that enhanced ejection fraction in porcine heart models.

Updated on Sept. 29, 2026 in Heart Disease

Close-up of a translucent, porous hydrogel membrane in a petri dish, illustrating advances in biomedical cardiac tissue engineering.
Researchers have successfully engineered a resilient hydrogel cardiac patch using chlorophyll as a crosslinker, showing promise in improving heart function in clinical models. AI Illustration. Upload story photo >

Live Poll

Does the use of sustainable materials in medical research increase your trust in future healthcare technology?

Scientists have successfully used chlorophyll as a physical crosslinker to create highly compressible hydrogels for tissue repair. This new material allowed for the fabrication of cardiac patches that improved ejection fraction by 11% in porcine infarcted hearts.

Why it matters

The development provides a novel way to create robust, macroporous hydrogels that can survive the mechanical stress of a beating heart. By using chlorophyll as an intrinsic antioxidant reservoir, the material supports cardiac tissue recovery more effectively than previous designs.

The hydrogel achieved a 90% maximum compressive strain, significantly higher than the 43% strain observed in standard GC hydrogels. The cardiac patches, measuring 36-mm in diameter, maintained an injection deformation rate of 90.4% without losing structural integrity.

The players

Nature

This is a prominent international scientific journal that publishes peer-reviewed research across all fields of science and technology.

The details

Chlorophyll functions as a physical crosslinker through self-assembly in aqueous solutions, forming nano-aggregations that serve as anchor points. Solvent exchange processes are then used to develop a macroporous structure, resulting in a material that is both highly resilient and capable of acting as an antioxidant reservoir.

Timeline

  1. September 29, 2026: The research findings were published in a peer-reviewed journal.

The Big Picture

This study advances the ongoing development of injectable hydrogel-based cardiac therapies by introducing a plant-derived antioxidant crosslinker. It marks a paradigm shift by demonstrating that natural organic molecules can structurally outperform traditional synthetic crosslinkers in biomedical engineering.

This development could eventually lead to new, minimally invasive treatment options for patients recovering from heart attacks. By utilizing a resilient patch that promotes tissue repair, future therapies may offer improved functional recovery compared to existing surgical interventions.

The takeaway

Using natural materials like chlorophyll represents a promising path for creating more durable medical implants. This work highlights how plant-based chemistry can solve engineering challenges in cardiac restoration while providing intrinsic therapeutic benefits.

Further reading

Learn more about the latest innovations in Heart Disease.

More information

Read the full results in the published peer-reviewed research article.

Source note: This article includes information reported by Nature.

Live Poll

Does the use of sustainable materials in medical research increase your trust in future healthcare technology?